DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $28,716,415 | +2062.4% | 618,089 | +1233.3% | 0.00% | – |
| Q1 2023 | $1,328,000 | +113114.0% | 46,357 | +23.3% | 0.00% | – |
| Q4 2022 | $1,173 | -99.8% | 37,582 | +51.2% | 0.00% | – |
| Q3 2022 | $504,000 | +62.1% | 24,854 | +24.3% | 0.00% | – |
| Q2 2022 | $311,000 | +61.1% | 19,990 | +98.1% | 0.00% | – |
| Q1 2022 | $193,000 | -10.2% | 10,089 | +18.4% | 0.00% | – |
| Q4 2021 | $215,000 | – | 8,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $102,737,575 | 55.73% |
| Sands Capital Ventures, LLC | 2,748,970 | $85,768 | 23.49% |
| OUP Management Co., LLC | 268,346 | $8,372,395 | 13.67% |
| New Leaf Venture Partners, L.L.C. | 371,693 | $11,596,822 | 8.40% |
| RA Capital Management | 6,848,911 | $213,686,023 | 4.33% |
| VR Adviser, LLC | 819,000 | $25,552,800 | 4.30% |
| SVB FINANCIAL GROUP | 42,358 | $1,321,570 | 3.61% |
| Logos Global Management LP | 660,000 | $20,592,000 | 2.41% |
| Deep Track Capital, LP | 1,734,143 | $54,105,262 | 2.27% |
| Samsara BioCapital, LLC | 202,773 | $6,326,518 | 1.36% |